Innoviva (INVA) Current Leases (2019 - 2026)
Innoviva (INVA) posted Current Leases of $646000.0 for Q1 2026, up 54.55% on a QoQ basis from $418000.0 in Q4 2025, and down 49.53% year-over-year from $1.3 million in Q1 2025.
Innoviva (INVA) Current Leases (2019 - 2026) Analysis & Trends
Innoviva's Current Leases history runs 5 years deep, the most recent figure standing at $646000.0 for Q1 2026.
- Quarterly Current Leases fell 49.53% year-over-year to $646000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $646000.0 (down 49.53% YoY) and the FY2025 annual result came in at $418000.0, down 73.41% from the prior year.
- Current Leases was $646000.0 for Q1 2026 at Innoviva, up from $418000.0 in the prior quarter.
- Across five years, Current Leases topped out at $1.6 million in Q4 2024 and bottomed at $418000.0 in Q4 2025.
- A 4-year average of $1.0 million and a median of $1.1 million in 2023 frame the typical range for Current Leases.
- Annual changes were most pronounced in 2024 — Current Leases soared 30.24% — and 2025, when it plunged 73.41%.
- Innoviva's Current Leases stood at $1.2 million in 2023, then surged by 30.24% to $1.6 million in 2024, then plunged by 73.41% to $418000.0 in 2025, then jumped by 54.55% to $646000.0 in 2026.
- Business Quant data shows INVA's Current Leases at $646000.0 in Q1 2026, $418000.0 in Q4 2025, and $680000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 531,233.95 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 20.58 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 872,589.03 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 720.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 11.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.61 Mn |
| 10 | Innoviva | 1.57 Bn | 969.11 Mn | 75.83 Mn | 646,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 646,000.00 |
| Dec 31, 2025 | 418,000.00 |
| Sep 30, 2025 | 680,000.00 |
| Jun 30, 2025 | 983,000.00 |
| Mar 31, 2025 | 1.28 Mn |
| Dec 31, 2024 | 1.57 Mn |
| Sep 30, 2024 | 1.51 Mn |
| Dec 31, 2023 | 1.21 Mn |
| Jun 30, 2019 | 317,000.00 |
| Mar 31, 2019 | 308,000.00 |